Drawing for PHAT LIPS

USPTO serial 98528539

PHAT LIPS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KENEALY, NATALIE LANGFORD
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHAT LIPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Len Smith

Len Smith Transformative Legal, LLC4160 N Craftsman Court, Suite 204Scottsdale, AZ 85251United States

Goods and services

ClassDescriptionStatusFirst use
005Products for aesthetic medical applications, namely, injectable lip rejuvenation products, namely, injectable preparations containing biological adipose tissue, biological platelets, or both biological adipose tissue and biological platelets, none of the foregoing products containing hemp or terpenesACTIVE—
010Products for aesthetic medical applications, namely, medical devices in the nature of injection needles and syringes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 5, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 5, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 13, 2026EX1GSOU EXTENSION 1 GRANTED—
Feb 13, 2026EXT1SOU EXTENSION 1 FILED—
Feb 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 2, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 8, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 8, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 6, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jun 6, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 6, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 6, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
May 29, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 29, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 29, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2024DOCKASSIGNED TO EXAMINER—
May 1, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 1, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance